TY  - JOUR
AU  - Decara, Juan M
AU  - Pavón, Francisco Javier
AU  - Suárez, Juan
AU  - Romero-Cuevas, Miguel
AU  - Baixeras, Elena
AU  - Vázquez, Mariam
AU  - Rivera, Patricia
AU  - Gavito, Ana L
AU  - Almeida, Bruno
AU  - Joglar, Jesús
AU  - de la Torre, Rafael
AU  - Rodríguez de Fonseca, Fernando
AU  - Serrano, Antonia
PY  - 2015
DO  - 10.1242/dmm.019919
SN  - 1754-8403
UR  - http://hdl.handle.net/10668/2342
T2  - Disease Models & Mechanisms
AB  - Fatty liver disease is one of the main hepatic complications associated with obesity. To date, there are no effective treatments for this pathology apart from the use of classical fibrates. In this study, we have characterized the in vivo effects of a...
LA  - en
PB  - Company of Biologists
KW  - Obesity
KW  - Non-alcoholic fatty liver disease
KW  - Zucker rats
KW  - Cannabinoid type 1 receptor
KW  - CB1
KW  - Peroxisome proliferator activated-receptor α
KW  - PPAR-α
KW  - Ratas zucker
KW  - Ácidos fíbricos
KW  - Homeostasis
KW  - Metabolismo liídico
KW  - Modelos animales
KW  - Obesidad
KW  - Ácido oleico
KW  - ARN mensajero
KW  - Tinción y etiquetado
KW  - Triglicéridos
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amines::Ethylamines::Phenethylamines::Amphetamines
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Terpenes::Cannabinoids
KW  - Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Cytochromes
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Carboxylic Acids::Acids, Acyclic::Butyric Acids::Isobutyric Acids::Fibric Acids
KW  - Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Physiological Processes::Homeostasis
KW  - Medical Subject Headings::Phenomena and Processes::Metabolic Phenomena::Metabolism::Lipid Metabolism
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Models, Animal
KW  - Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Body Constitution::Body Weights and Measures::Body Size::Body Weight::Overweight::Obesity
KW  - Medical Subject Headings::Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids, Unsaturated::Fatty Acids, Monounsaturated::Oleic Acids
KW  - Medical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA::RNA, Messenger
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats::Rats, Mutant Strains::Rats, Zucker
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Clinical Laboratory Techniques::Histological Techniques::Histocytological Preparation Techniques::Staining and Labeling
KW  - Medical Subject Headings::Chemicals and Drugs::Lipids::Glycerides::Triglycerides
KW  - Medical Subject Headings::Diseases::Digestive System Diseases::Liver Diseases::Fatty Liver::Non-alcoholic Fatty Liver Disease
KW  - Medical Subject Headings::Diseases Category::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions
TI  - Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
TY  - research article
ER  -